SecSonar.com

National Research Corporation (NRC)

National Research Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

National Research Corporation (NRC) is a Medical - Healthcare Information Services company based in US with a market capitalization of $449.9M. Revenue declined 4.0% year-over-year and the company generated $15.7M in free cash flow. This page tracks NRC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 368 employees · IPO May 23, 2013

Valuation

Valuation & price

$18.62 · as of May 17, 2026 · -17.2% vs 52w high

35.9

P/E ratio

Latest-FY diluted EPS

32.16

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$22.48$16.95$11.42Jul 25Dec 25Jul 26Jul 7, 25$16.47Jul 9, 25$16.74Jul 11, 25$15.96Jul 15, 25$15.10Jul 17, 25$14.95Jul 21, 25$14.05Jul 23, 25$14.73Jul 25, 25$13.89Jul 29, 25$13.26Jul 31, 25$12.50Aug 4, 25$13.66Aug 6, 25$14.16Aug 11, 25$15.09Aug 13, 25$15.57Aug 15, 25$15.31Aug 19, 25$16.17Aug 21, 25$14.51Aug 25, 25$15.26Aug 27, 25$15.48Aug 29, 25$14.69Sep 3, 25$14.73Sep 5, 25$15.40Sep 9, 25$16.14Sep 11, 25$16.20Sep 16, 25$16.06Sep 18, 25$15.89Sep 22, 25$15.22Sep 24, 25$14.55Sep 26, 25$13.30Sep 30, 25$12.78Oct 2, 25$12.46Oct 6, 25$12.07Oct 8, 25$11.92Oct 10, 25$11.48Oct 14, 25$11.52Oct 16, 25$11.68Oct 21, 25$12.09Oct 23, 25$11.66Oct 27, 25$11.42Oct 29, 25$13.45Oct 31, 25$13.36Nov 4, 25$13.78Nov 6, 25$14.34Nov 10, 25$14.48Nov 12, 25$15.43Nov 14, 25$15.23Nov 18, 25$16.05Nov 20, 25$16.61Nov 25, 25$18.02Nov 28, 25$16.99Dec 2, 25$16.20Dec 4, 25$16.32Dec 8, 25$15.85Dec 10, 25$16.93Dec 12, 25$17.64Dec 16, 25$18.43Dec 18, 25$19.30Dec 22, 25$18.88Dec 24, 25$18.81Dec 29, 25$18.97Jan 2, 26$18.03Jan 6, 26$19.30Jan 8, 26$19.49Jan 12, 26$20.43Jan 14, 26$20.84Jan 16, 26$22.22Jan 21, 26$22.48Jan 23, 26$21.07Jan 27, 26$20.35Jan 29, 26$20.05Feb 2, 26$21.90Feb 4, 26$15.27Feb 9, 26$15.37Feb 11, 26$13.75Feb 13, 26$12.08Feb 18, 26$12.33Feb 20, 26$13.67Feb 24, 26$12.49Feb 26, 26$13.44Mar 2, 26$13.85Mar 4, 26$13.12Mar 6, 26$14.59Mar 10, 26$16.27Mar 12, 26$16.50Mar 17, 26$17.73Mar 19, 26$17.31Mar 23, 26$17.51Mar 25, 26$17.18Mar 27, 26$17.13Mar 31, 26$16.98Apr 2, 26$17.16Apr 7, 26$17.04Apr 9, 26$17.05Apr 13, 26$16.82Apr 15, 26$17.84Apr 17, 26$18.03Apr 22, 26$17.50Apr 24, 26$17.23Apr 28, 26$16.84Apr 30, 26$16.46May 4, 26$18.22May 6, 26$17.86May 8, 26$18.75May 12, 26$19.19May 14, 26$18.93May 18, 26$18.74May 20, 26$19.26May 22, 26$19.08May 28, 26$19.66Jun 1, 26$20.25Jun 3, 26$19.04Jun 5, 26$19.14Jun 9, 26$19.75Jun 11, 26$18.79Jun 15, 26$18.31Jun 17, 26$17.75Jun 22, 26$19.49Jun 24, 26$20.70Jun 26, 26$20.81Jul 2, 26$22.40
$11.4252-week range$22.48
Loading valuation history…

Fundamentals

Key fundamentals

$449.9M

Market cap

-4.0%

Revenue growth (YoY)

56.3%

Gross margin

$15.7M

Free cash flow (USD)

$74.9M

Net debt

-5.6%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$109.4MFY 2017$117.6MFY 2018$119.7MFY 2019$128.0MFY 2020$133.3MFY 2021$148.0MFY 2022$151.6MFY 2023$148.6MFY 2024$143.1MFY 2025$137.4M
$109.4M$137.4M

Free cash flow by year

2016 → 2025

FY 2016$22.9MFY 2017$23.3MFY 2018$33.9MFY 2019$36.3MFY 2020$36.7MFY 2021$40.8MFY 2022$26.4MFY 2023$22.3MFY 2024$19.2MFY 2025$15.7M
$22.9M$15.7M

Gross margin by year

2021 → 2025

FY 202164.6%FY 202262.4%FY 202362.3%FY 202460.2%FY 202556.3%
64.6%56.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBylaws AmendedJun 29, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing
  • 8-K eventEarnings ReleaseApr 28, 2026Filing
  • 8-K eventEquity Awards AmendmentApr 28, 2026Filing
  • Annual report10-K FiledApr 28, 2026Filing
  • 8-K eventBylaw AmendmentApr 20, 2026Filing

Questions

Frequently asked questions

What is National Research Corporation's market cap?

National Research Corporation (NRC) has a market capitalization of $449.9M.

What is NRC's P/E ratio?

NRC trades at a price-to-earnings ratio of 35.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is NRC's price-to-book (P/B) ratio?

NRC trades at 32.16 times book value per share.

Are insiders buying NRC stock?

SEC Form 4 filings show no open-market insider buys at National Research Corporation in the last 90 days (0 sells).

Same arena

Related companies in Medical - Healthcare Information Services

EVH

Evolent Health, Inc.

$443.7M

CTEV

Claritev Corporation

$428.8M

TBRG

TruBridge, Inc.

$389.2M

SOPH

SOPHiA GENETICS S.A.

$360M

SLP

Simulations Plus, Inc.

$349.2M

PHR

Phreesia, Inc.

$606.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.